尿激酶联合肝素治疗不稳定性心绞痛

Use of urokinase combined with heparin in the treatment of unstable angina pectoris

针对ＵＡ的主要病理机制，观察ＵＫ联合肝素治疗ＵＡ的疗效。分析ＵＡ病人５９例，结果：对照组显效１９／２９例，占６５５％，治疗组显效２７／３０例，占９０％，二组间差异显著（Ｐ＜００５）。按ＵＡ显效时间与对照组比较，治疗组缩短３６６％。发生ＡＭＩ者，对照组１０５％，治疗组３５％，统计学差别不显著。试验结果表明常规抗心绞痛药物治疗基础上加用ＵＫ和小剂量肝素可提高ＵＡ疗效，迅速控制症状，并且安全可靠。

Fiftynine patients with unstable angina pectoris (UA) were observed. The results showed: effective rate of control group was 655%(19/29),and of curative group was 90% (27/30).The difference was significant (P<005).The effecacyarising time shortered 366% compared with the control group. In control group 105% of patients suffered from AMI while it was 35% in curative group. The difference was not significant. It is proved that this teratment is safe and effective.